Spontaneous Intraventricular Hemorrhage: When Should Intraventricular tPA Be Considered?

Abstract

Spontaneous intracerebral hemorrhage (ICH) is the most common cause of intraventricular hemorrhage (IVH) in adults. Complicating approximately 40% of ICH cases, IVH adds to the morbidity and mortality of this often fatal form of stroke. It is also a severity factor that complicates subarachnoid hemorrhage and traumatic brain injury, along with other less common causes of intracranial bleeding. Medical and surgical interventions to date have focused on limiting ICH and IVH expansion, controlling intracranial pressure, and relieving obstructive hydrocephalus. The placement of an external ventricular drain (EVD) can achieve the latter two goals but has not demonstrated improvement in clinical outcomes beyond mortality reduction. More recently, intraventricular fibrinolysis, utilizing the EVD, has gained interest as a safe and potentially effective method to maintain catheter patency and facilitate hematoma removal. A recent phase III clinical trial evaluating the efficacy of intraventricular alteplase versus intraventricular saline showed a mortality benefit, but failed to meet the primary endpoint of significant functional improvement. However, planned subgroup analysis focusing on patients with IVH volume > 20 mL, and those with IVH removal > 85% suggest that significant functional benefits may be attainable with this therapy. The practice of intraventricular fibrinolysis for spontaneous IVH is not the standard of care; however, based on 20 years of experience, it meets thresholds as a safe intervention, and in those patients with a high burden of intraventricular blood, aggressive clearance may lead to improved quality of life in survivors of this morbid syndrome.

Keywords

intracerebral hemorrhage - intraventricular hemorrhage - fibrinolysis - thrombolysis - hydrocephalus - Graeb - alteplase - external ventricular drain - ventriculostomy

• References

• 1 Black M, Graham DI. Sudden unexplained death in adults caused by intracranial pathology. J Clin Pathol 2002; 55 (01) 44-50
• 2 Dey M, Stadnik A, Awad IA. Thrombolytic evacuation of intracerebral and intraventricular hemorrhage. Curr Cardiol Rep 2012; 14 (06) 754-760
• 3 Ojemann RG, Heros RC. Spontaneous brain hemorrhage. Stroke 1983; 14 (04) 468-475
• 4 Hanley DF. Intraventricular hemorrhage: severity factor and treatment target in spontaneous intracerebral hemorrhage. Stroke 2009; 40 (04) 1533-1538
• 5 Mohr G, Ferguson G, Khan M. , et al. Intraventricular hemorrhage from ruptured aneurysm. Retrospective analysis of 91 cases. J Neurosurg 1983; 58 (04) 482-487
• 6 Steiner T, Diringer MN, Schneider D. , et al. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery 2006; 59 (04) 767-773 , discussion 773–774
• 7 Sanders E. A study of primary, immediate, or direct hemorrhage into the ventricles of the brain. Am J Med Sci 1881; 82: 85-128
• 8 Irie F, Fujimoto S, Uda K. , et al. Primary intraventricular hemorrhage from dural arteriovenous fistula. J Neurol Sci 2003; 215 (1-2): 115-118
• 9 Kramer AH, Roberts DJ, Holodinsky J. , et al. Intraventricular tissue plasminogen activator in subarachnoid hemorrhage patients: a prospective, randomized, placebo-controlled pilot trial. Neurocrit Care 2014; 21 (02) 275-284
• 10 Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet 2009; 373 (9675): 1632-1644
• 11 Young WB, Lee KP, Pessin MS, Kwan ES, Rand WM, Caplan LR. Prognostic significance of ventricular blood in supratentorial hemorrhage: a volumetric study. Neurology 1990; 40 (04) 616-619
• 12 Tuhrim S, Dambrosia JM, Price TR. , et al. Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol 1991; 29 (06) 658-663
• 13 Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med 1999; 27 (03) 617-621
• 14 Hallevi H, Albright KC, Aronowski J. , et al. Intraventricular hemorrhage: anatomic relationships and clinical implications. Neurology 2008; 70 (11) 848-852
• 15 Delcourt C, Zheng D, Chen X. , et al. Associations with health-related quality of life after intracerebral haemorrhage: pooled analysis of INTERACT studies. J Neurol Neurosurg Psychiatry 2017; 88 (01) 70-75
• 16 Horstmann S, Rizos T, Lauseker M. , et al. Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study. J Neurol 2013; 260 (08) 2046-2051
• 17 Gordon A. Primary ventricular hemorrhage: further contribution to a characteristic symptom group. Arch Neurol Psychiatry 1938; 39: 1272-1276
• 18 Gates PC, Barnett HJ, Vinters HV, Simonsen RL, Siu K. Primary intraventricular hemorrhage in adults. Stroke 1986; 17 (05) 872-877
• 19 Staykov D, Bardutzky J, Huttner HB, Schwab S. Intraventricular fibrinolysis for intracerebral hemorrhage with severe ventricular involvement. Neurocrit Care 2011; 15 (01) 194-209
• 20 Maas MB, Nemeth AJ, Rosenberg NF, Kosteva AR, Prabhakaran S, Naidech AM. Delayed intraventricular hemorrhage is common and worsens outcomes in intracerebral hemorrhage. Neurology 2013; 80 (14) 1295-1299
• 21 Witsch J, Bruce E, Meyers E. , et al. Intraventricular hemorrhage expansion in patients with spontaneous intracerebral hemorrhage. Neurology 2015; 84 (10) 989-994
• 22 Moullaali TJ, Sato S, Wang X. , et al. Prognostic significance of delayed intraventricular haemorrhage in the INTERACT studies. J Neurol Neurosurg Psychiatry 2017; 88 (01) 19-24
• 23 Ziai W, Ullman N, Thompson C. , et al. Stabilizing Bleeding Prior To Acute Therapies for Spontaneous Intracerebral Hemorrhage. In: Abstract. 3215. International Stroke Conference (ISC), San Diego, CA; 2014
• 24 Hemphill III JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001; 32 (04) 891-897
• 25 Frontera JA, Claassen J, Schmidt JM. , et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery 2006; 59 (01) 21-27 , discussion 21–27
• 26 Claassen J, Bernardini GL, Kreiter K. , et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke 2001; 32 (09) 2012-2020
• 27 Mata-Mbemba D, Mugikura S, Nakagawa A. , et al. Intraventricular hemorrhage on initial computed tomography as marker of diffuse axonal injury after traumatic brain injury. J Neurotrauma 2015; 32 (05) 359-365
• 28 Kothari RU, Brott T, Broderick JP. , et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996; 27 (08) 1304-1305
• 29 Hallevi H, Dar NS, Barreto AD. , et al. The IVH score: a novel tool for estimating intraventricular hemorrhage volume: clinical and research implications. Crit Care Med 2009; 37 (03) 969-974 , e1
• 30 Graeb DA, Robertson WD, Lapointe JS, Nugent RA, Harrison PB. Computed tomographic diagnosis of intraventricular hemorrhage. Etiology and prognosis. Radiology 1982; 143 (01) 91-96
• 31 Morgan TC, Dawson J, Spengler D. , et al; CLEAR and VISTA Investigators. The Modified Graeb Score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome. Stroke 2013; 44 (03) 635-641
• 32 Hansen BM, Morgan TC, Betz JF. , et al. Intraventricular extension of supratentorial intracerebral hemorrhage: the modified Graeb scale improves outcome prediction in Lund Stroke Register. Neuroepidemiology 2016; 46 (01) 43-50
• 33 Klaas JP, Braksick S, Mandrekar J. , et al. Factors associated with the need for intensive care unit admission following supratentorial intracerebral hemorrhage: the Triage ICH Model. Neurocrit Care 2017; 27 (01) 75-81
• 34 Wartenberg KE, Wang X, Muñoz-Venturelli P. , et al. Intensive care unit admission for patients in the INTERACT2 ICH blood pressure treatment trial: characteristics, predictors, and outcomes. Neurocrit Care 2017; 26 (03) 371-378
• 35 Vial F, Brunser A, Lavados P, Illanes S. Intraventricular bleeding and hematoma size as predictors of infection development in intracerebral hemorrhage: a prospective cohort study. J Stroke Cerebrovasc Dis 2016; 25 (11) 2708-2711
• 36 Hemphill III JC, Greenberg SM, Anderson CS. , et al; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015; 46 (07) 2032-2060
• 37 Steiner T, Al-Shahi Salman R, Beer R. , et al; European Stroke Organisation. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke 2014; 9 (07) 840-855
• 38 Chan E, Anderson CS, Wang X. , et al; INTERACT Investigators. Early blood pressure lowering does not reduce growth of intraventricular hemorrhage following acute intracerebral hemorrhage: results of the INTERACT studies. Cerebrovasc Dis Extra 2016; 6 (03) 71-75
• 39 Hallevi H, Walker KC, Kasam M, Bornstein N, Grotta JC, Savitz SI. Inflammatory response to intraventricular hemorrhage: time course, magnitude and effect of t-PA. J Neurol Sci 2012; 315 (1-2): 93-95
• 40 Nieuwkamp DJ, de Gans K, Rinkel GJ, Algra A. Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol 2000; 247 (02) 117-121
• 41 Dey M, Jaffe J, Stadnik A, Awad IA. External ventricular drainage for intraventricular hemorrhage. Curr Neurol Neurosci Rep 2012; 12 (01) 24-33
• 42 Lovasik BP, McCracken DJ, McCracken CE. , et al. The effect of external ventricular drain use in intracerebral hemorrhage. World Neurosurg 2016; 94: 309-318
• 43 Herrick DB, Ullman N, Nekoovaght-Tak S. , et al. Determinants of external ventricular drain placement and associated outcomes in patients with spontaneous intraventricular hemorrhage. Neurocrit Care 2014; 21 (03) 426-434
• 44 Hughes JD, Puffer R, Rabinstein AA. Risk factors for hydrocephalus requiring external ventricular drainage in patients with intraventricular hemorrhage. J Neurosurg 2015; 123 (06) 1439-1446
• 45 Jaffe J, Melnychuk E, Muschelli J. , et al. Ventricular catheter location and the clearance of intraventricular hemorrhage. Neurosurgery 2012; 70 (05) 1258-1263 , discussion 1263–1264
• 46 Fargen KM, Hoh BL, Neal D, O'connor T, Rivera-Zengotita M, Murad GJA. The burden and risk factors of ventriculostomy occlusion in a high-volume cerebrovascular practice: results of an ongoing prospective database. J Neurosurg 2016; 124 (06) 1805-1812
• 47 Gilard V, Djoubairou BO, Lepetit A. , et al. Small versus large catheters for ventriculostomy in the management of intraventricular hemorrhage. World Neurosurg 2017; 97: 117-122
• 48 Liu DZ, Waldau B, Ander BP. , et al. Inhibition of Src family kinases improves cognitive function after intraventricular hemorrhage or intraventricular thrombin. J Cereb Blood Flow Metab 2017; 37 (07) 2359-2367
• 49 Wagner KR, Xi G, Hua Y. , et al. Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protection. J Neurosurg 1999; 90 (03) 491-498
• 50 Mayfrank L, Kim Y, Kissler J. , et al. Morphological changes following experimental intraventricular haemorrhage and intraventricular fibrinolytic treatment with recombinant tissue plasminogen activator. Acta Neuropathol 2000; 100 (05) 561-567
• 51 Narayan RK, Narayan TM, Katz DA, Kornblith PL, Murano G. Lysis of intracranial hematomas with urokinase in a rabbit model. J Neurosurg 1985; 62 (04) 580-586
• 52 Lapointe M, Haines S. Fibrinolytic therapy for intraventricular hemorrhage in adults. Cochrane Database Syst Rev 2002; (03) CD003692
• 53 Gaberel T, Magheru C, Parienti JJ, Huttner HB, Vivien D, Emery E. Intraventricular fibrinolysis versus external ventricular drainage alone in intraventricular hemorrhage: a meta-analysis. Stroke 2011; 42 (10) 2776-2781
• 54 Naff N, Williams MA, Keyl PM. , et al. Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke 2011; 42 (11) 3009-3016
• 55 Khan NR, Tsivgoulis G, Lee SL. , et al. Fibrinolysis for intraventricular hemorrhage: an updated meta-analysis and systematic review of the literature. Stroke 2014; 45 (09) 2662-2669
• 56 Moradiya Y, Murthy SB, Newman-Toker DE, Hanley DF, Ziai WC. Intraventricular thrombolysis in intracerebral hemorrhage requiring ventriculostomy: a decade-long real-world experience. Stroke 2014; 45 (09) 2629-2635
• 57 Varelas PN, Rickert KL, Cusick J. , et al. Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator. Neurosurgery 2005; 56 (02) 205-213 , discussion 205–213
• 58 Hanley DF, Lane K, McBee N. , et al; CLEAR III Investigators. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet 2017; 389 (10069): 603-611
• 59 Litrico S, Almairac F, Gaberel T. , et al. Intraventricular fibrinolysis for severe aneurysmal intraventricular hemorrhage: a randomized controlled trial and meta-analysis. Neurosurg Rev 2013; 36 (04) 523-530 , discussion 530–531
• 60 Ramakrishna R, Sekhar LN, Ramanathan D. , et al. Intraventricular tissue plasminogen activator for the prevention of vasospasm and hydrocephalus after aneurysmal subarachnoid hemorrhage. Neurosurgery 2010; 67 (01) 110-117 , discussion 117
• 61 Findlay JM, Jacka MJ. Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage. Neurosurgery 2004; 55 (03) 532-537 , discussion 537–538
• 62 Ziai WC, Tuhrim S, Lane K. , et al; CLEAR III Investigators. A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III). Int J Stroke 2014; 9 (04) 536-542
• 63 Rabinstein AA. Intracerebral haemorrhage: no good treatment but treatment helps. Lancet 2017; 389 (10069): 575-576
• 64 Staykov D, Huttner HB, Lunkenheimer J. , et al. Single versus bilateral external ventricular drainage for intraventricular fibrinolysis in severe ventricular haemorrhage. J Neurol Neurosurg Psychiatry 2010; 81 (01) 105-108
• 65 Hinson HE, Melnychuk E, Muschelli J, Hanley DF, Awad IA, Ziai WC. Drainage efficiency with dual versus single catheters in severe intraventricular hemorrhage. Neurocrit Care 2012; 16 (03) 399-405
• 66 Du B, Wang J, Zhong XL. , et al. Single versus bilateral external ventricular drainage for intraventricular fibrinolysis using urokinase in severe ventricular haemorrhage. Brain Inj 2014; 28 (11) 1413-1416
• 67 Ziai W, Awad I, Hanley D. Efficiency of intraventricular hemorrhage removal in the clot lysis: evaluation of Accelerated Resolution of Intraventricular Hemorrhage Trial (CLEAR III). In: Abstract Number: AS02–020. 3rd European Stroke Organization Conference (ESOC 2017), Prague, Czech; 2017
• 68 Naff NJ, Williams MA, Rigamonti D, Keyl PM, Hanley DF. Blood clot resolution in human cerebrospinal fluid: evidence of first-order kinetics. Neurosurgery 2001; 49 (03) 614-619 , discussion 619–621
• 69 Hanley D. Final results CLEARIVH Trial: clot lysis, safety and 30 day functional outcomes. In: Abstract Presentation at the European Stroke Conference, Nice, France, May 13–16, 2008
• 70 Wang YC, Lin CW, Shen CC, Lai SC, Kuo JS. Tissue plasminogen activator for the treatment of intraventricular hematoma: the dose-effect relationship. J Neurol Sci 2002; 202 (1-2): 35-41
• 71 Ducruet AF, Hickman ZL, Zacharia BE. , et al. Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage. Neurosurgery 2010; 66 (04) 648-655
• 72 Ziai W, Moullaali T, Nekoovaght-Tak S. , et al. No exacerbation of perihematomal edema with intraventricular tissue plasminogen activator in patients with spontaneous intraventricular hemorrhage. Neurocrit Care 2013; 18 (03) 354-361
• 73 Volbers B, Wagner I, Willfarth W, Doerfler A, Schwab S, Staykov D. Intraventricular fibrinolysis does not increase perihemorrhagic edema after intracerebral hemorrhage. Stroke 2013; 44 (02) 362-366
• 74 Kornbluth J, Nekoovaght-Tak S, Ullman N, Carhuapoma JR, Hanley DF, Ziai W. Early quantification of hematoma Hounsfield units on noncontrast CT in acute intraventricular hemorrhage predicts ventricular clearance after intraventricular thrombolysis. AJNR Am J Neuroradiol 2015; 36 (09) 1609-1615
• 75 Ziai WC, Muschelli J, Thompson CB. , et al. Factors affecting clot lysis rates in patients with spontaneous intraventricular hemorrhage. Stroke 2012; 43 (05) 1234-1239
• 76 Broderick J, Lu M, Jackson C. , et al; NINDS t-PA Stroke Study Group. Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke. Ann Neurol 2001; 49 (06) 736-744
• 77 González-Conejero R, Fernández-Cadenas I, Iniesta JA. , et al; Proyecto Ictus Research Group. Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients. Stroke 2006; 37 (09) 2288-2293
• 78 Fernandez-Cadenas I, Alvarez-Sabin J, Ribo M. , et al. Influence of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 gene polymorphisms on tissue-type plasminogen activator-induced recanalization in ischemic stroke patients. J Thromb Haemost 2007; 5 (09) 1862-1868
• 79 Fernández-Cadenas I, Del Río-Espínola A, Giralt D. , et al. IL1B and VWF variants are associated with fibrinolytic early recanalization in patients with ischemic stroke. Stroke 2012; 43 (10) 2659-2665
• 80 Montaner J, Fernández-Cadenas I, Molina CA. , et al. Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene. Stroke 2003; 34 (12) 2851-2855
• 81 Staykov D, Kuramatsu JB, Bardutzky J. , et al. Efficacy and safety of combined intraventricular fibrinolysis with lumbar drainage for prevention of permanent shunt dependency after intracerebral hemorrhage with severe ventricular involvement: A randomized trial and individual patient data meta-analysis. Ann Neurol 2017; 81 (01) 93-103
• 82 Wolf S. EARLYdrain - Outcome after Early Lumbar CSF-drainage in Aneurysmal SAH (EARLYDRAIN). Identifier: NCT01258257. Available at: https://clinicaltrials.gov/ct2/show/NCT01258257 . Accessed 2016
• 83 Diringer MN, Edwards DF, Zazulia AR. Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial intracerebral hemorrhage. Stroke 1998; 29 (07) 1352-1357
• 84 Adams RE, Diringer MN. Response to external ventricular drainage in spontaneous intracerebral hemorrhage with hydrocephalus. Neurology 1998; 50 (02) 519-523
• 85 Phan TG, Koh M, Vierkant RA, Wijdicks EF. Hydrocephalus is a determinant of early mortality in putaminal hemorrhage. Stroke 2000; 31 (09) 2157-2162
• 86 Liliang PC, Liang CL, Lu CH. , et al. Hypertensive caudate hemorrhage prognostic predictor, outcome, and role of external ventricular drainage. Stroke 2001; 32 (05) 1195-1200
• 87 Bhattathiri PS, Gregson B, Prasad KS, Mendelow AD. ; STICH Investigators. Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the STICH trial. Acta Neurochir Suppl (Wien) 2006; 96: 65-68
• 88 Woo D, Kruger AJ, Sekar P. , et al. Incontinence and gait disturbance after intraventricular extension of intracerebral hemorrhage. Neurology 2016; 86 (10) 905-911
• 89 Coplin WM, Vinas FC, Agris JM. , et al. A cohort study of the safety and feasibility of intraventricular urokinase for nonaneurysmal spontaneous intraventricular hemorrhage. Stroke 1998; 29 (08) 1573-1579
• 90 Ziai WC, Torbey MT, Naff NJ. , et al. Frequency of sustained intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Cerebrovasc Dis 2009; 27 (04) 403-410
• 91 Ziai WC, Melnychuk E, Thompson CB, Awad I, Lane K, Hanley DF. Occurrence and impact of intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Crit Care Med 2012; 40 (05) 1601-1608
• 92 Hinson HE, Hanley DF, Ziai WC. Management of intraventricular hemorrhage. Curr Neurol Neurosci Rep 2010; 10 (02) 73-82
• 93 Nyquist P, Hanley DF. The use of intraventricular thrombolytics in intraventricular hemorrhage. J Neurol Sci 2007; 261 (1-2): 84-88
• 94 Chen Q, Tang J, Tan L. , et al. Intracerebral hematoma contributes to hydrocephalus after intraventricular hemorrhage via aggravating iron accumulation. Stroke 2015; 46 (10) 2902-2908
• 95 Fam MD, Pang A, Zeineddine HA. , et al; CLEAR III Trial Investigators. Demographic risk factors for vascular lesions as etiology of intraventricular hemorrhage in prospectively screened cases. Cerebrovasc Dis 2017; 43 (5-6): 223-230
• 96 Chen CC, Liu CL, Tung YN. , et al. Endoscopic surgery for intraventricular hemorrhage (IVH) caused by thalamic hemorrhage: comparisons of endoscopic surgery and external ventricular drainage (EVD) surgery. World Neurosurg 2011; 75 (02) 264-268
• 97 Zhang Z, Li X, Liu Y, Shao Y, Xu S, Yang Y. Application of neuroendoscopy in the treatment of intraventricular hemorrhage. Cerebrovasc Dis 2007; 24 (01) 91-96
• 98 Li Y, Zhang H, Wang X. , et al. Neuroendoscopic surgery versus external ventricular drainage alone or with intraventricular fibrinolysis for intraventricular hemorrhage secondary to spontaneous supratentorial hemorrhage: a systematic review and meta-analysis. PLoS One 2013; 8 (11) e80599
• 99 Naff NJ, Hanley DF, Keyl PM. , et al. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery 2004; 54 (03) 577-583 , discussion 583–584
• 100 Naff NJ, Carhuapoma JR, Williams MA. , et al. Treatment of intraventricular hemorrhage with urokinase: effects on 30-Day survival. Stroke 2000; 31 (04) 841-847
• 101 Tung MY, Ong PL, Seow WT, Tan KK. A study on the efficacy of intraventricular urokinase in the treatment of intraventricular haemorrhage. Br J Neurosurg 1998; 12 (03) 234-239
• 102 Akdemir H, Selçuklu A, Paşaoğlu A, Oktem IS, Kavuncu I. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. Neurosurg Rev 1995; 18 (02) 95-100
• 103 Torres A, Plans G, Martino J. , et al. Fibrinolytic therapy in spontaneous intraventricular haemorrhage: efficacy and safety of the treatment. Br J Neurosurg 2008; 22 (02) 269-274
• 104 Huttner HB, Tognoni E, Bardutzky J. , et al. Influence of intraventricular fibrinolytic therapy with rt-PA on the long-term outcome of treated patients with spontaneous basal ganglia hemorrhage: a case-control study. Eur J Neurol 2008; 15 (04) 342-349
• 105 Rainov NG, Burkert WL. Urokinase infusion for severe intraventricular haemorrhage. Acta Neurochir (Wien) 1995; 134 (1-2): 55-59
• 106 Todo T, Usui M, Takakura K. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. J Neurosurg 1991; 74 (01) 81-86